Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions

Phase 1/2 Unknown 50 enrolled Zhejiang University Yake Biotechnology Ltd. · collab

NaSingle-groupOpen-labelTreatment

Summary

Clinical trial for the safety and efficacy of sequential radiotherapy with CAR-T cells in the treatment of relapsed and refractory hematological malignancies with extramedullary lesions

Timeline

Start: 2021-03
Primary completion: 2024-03
Completion: 2025-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CAR-T cells	Cell therapy	—	Intravenous

Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions

Summary

Timeline

Drugs

Indications